Widespread vaccination is a pillar of outbreak control for a variety of diseases. But few resources are available to assess how vaccine presentation and target population characteristics affect coverage rates. How can more vaccines become vaccinations?
For more than two decades, Paul Clyde has worked with dozens of companies experimenting with different business models in low- and middle-income countries.